Central Sleep Apnea in Heart Failure: How Mechanisms May Guide Treatment
Official title: Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment
Run by VA Office of Research and Development · NCT07210606 · Data updated 2026-11-12
This study tests whether combining positive airway pressure with a medication (trazodone) or oxygen can reduce central sleep apnea in Veterans with heart failure and ensure better breathing during sleep.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 1 site (Detroit, Michigan) |
| Status | Recruiting |
| Started | September 16, 2026 |
| Main results expected | June 30, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | October 13, 2026 |
| Trial ID | NCT07210606 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Veterans with central sleep apnea (AHI >15/hour, CAHI >5/hour) and chronic stable heart failure with reduced ejection fraction, on optimized guideline-based therapy for at least 90 days.
✕Probably not a fit
Patients who do not tolerate PAP therapy, have obstructive lung disease, or are currently receiving CSA treatment may be less likely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial investigates mechanistic pathways underlying central sleep apnea in people with heart failure and reduced ejection fraction. It uses a multi-modality approach, pairing PAP therapy to keep airways open with pharmacologic or supplemental oxygen strategies to address the brain’s breathing control. Specific aims assess whether lowering respiratory arousals and reducing peripheral chemoreceptor sensitivity widen the CO2 reserve and decrease CSA indices. The setting involves Veterans, with stable heart failure management, at the John D. Dingell VA Medical Center. Results could inform future multi-modality treatment strategies for CSA in this population.
Why it matters
Potential benefit: If successful, the approach could improve sleep breathing, quality of life, and long-term outcomes for patients with CSA and heart failure.
How similar studies have gone: Prior studies suggest limited efficacy of single-modality therapies; combining interventions is a novel approach with potential for improved outcomes, though evidence is still emerging.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women Veterans with central sleep apnea, defined as Apnea Hypopnea Index (AHI)\>15/hour with CAHI\>5/hour, will be included with the experiments * Those with chronic, stable heart failure with reduced ejection fraction, receiving stable optimized guideline-based therapy and no hospitalizations or change in the medical regimen for the past 90 days before enrollment Exclusion Criteria: * Pregnant or breastfeeding females * Moderate or severe obstructive or restrictive lung disease, including supplemental oxygen (O2) use * Current treatment for central sleep apnea (CSA), including any form of positive airway pressure (PAP) in the past three months, or phrenic nerve situation * Too ill to engage in the study procedures, inability to provide consent for participation * A history of cardiac arrhythmia * Alcohol or substance abuse (less than 90 days sobriety) or current participation in a treatment program * Depression or a history of suicidality * Severe insomnia (ISI\>21) or reported short sleep duration (\<6 hours) * Positive airway pressure (PAP)-emergent central sleep apnea * Lack of positive airway pressure (PAP) acceptance/adherence after a one-week home PAP trial after enrollment Additional Trazodone Exclusions: * Prolonged QT on baseline electrocardiogram (ECG), using medications that inhibit CYP3A4 * Patients with severe renal impairment (glomerular filtration rate (GFR) \< 20 milliliters per minute/1.73 square meters) or end-stage renal disease
Where it's running
-
John D. Dingell VA Medical Center, Detroit, MI
Detroit, Michigan, United States Recruiting
Study contacts
- Principal investigator: M Safwan Badr, MD — John D. Dingell VA Medical Center, Detroit, MI
- Study coordinator: M S Badr, MD
- Email: sbadr@med.wayne.edu
- Phone: (313) 576-1000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exploring treatments for central sleep apnea
This study is testing new combination treatments for central sleep apnea in veterans to see if they can help improve breathing and quality of life.
-
Respiratory progression in adults with Duchenne muscular dystrophy: a long-term observational study
This study tests how respiratory function changes over three years in adults with genetically confirmed Duchenne muscular dystrophy.
-
Tonsillectomy Added to Hypoglossal Nerve Stimulation for OSA with Lateral Wall Collapse
In adults with obstructive sleep apnea and side-wide airway collapse, this study tests whether adding tonsil removal to hypoglossal nerve stimulation helps more than hypoglossal nerve stimulation alone.
-
Combined upper-airway electrical stimulation with a drug combo for sleep apnea
This study tests whether adding a drug mix called AtoOxy to an existing hypoglossal nerve stimulation device helps people with sleep apnea sleep better.
-
Neck nerve stimulation to map spinal and brain sensory pathways
We will test whether brief electrical pulses applied to neck nerve roots can reveal spinal and brain sensory responses in people with chronic stroke and control patients undergoing cervical surgery.
-
Combining non-invasive brain and spinal cord stimulation to improve arm and hand function
This study tests whether pairing non-invasive brain stimulation (tDCS) with spinal cord stimulation (tSCS) during a cognitive-motor task can improve sensorimotor and cognitive-motor function in people with cervical spinal cord injury or stroke compared with each stimulation alone or sham.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.